PhoenixBio Co.,Ltd. (6190) Other
Market cap
¥1.5B
P/E ratio
19.6x
Phoenix Bio provides pharmaceutical testing services using PXB mice with human liver cells to help drug companies predict how medicines work in people.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Return on Assets | - | - | - | - | 6.8 | 5.4 | -1.9 | -1.8 | -9.8 | 4.1 | -9.4 | 18.6 | 0.9 | -11.8 | 7.8 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 62 | 60 | 40 | 44 | 48 | 53 | 63 | 72 | 71 | 69 | 66 | 65 | 70 | 69 | - |